+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma



Immunomagnetic purging of bone marrow grafts for autologous transplantation in neuroblastoma



Acta Clinica Belgica 45(2): 97-106



Bone marrow grafts of 5 patients with stage IV neuroblastoma and one patient with stage IV retinoblastoma were harvested during complete remission and in vitro processed for autologous transplantation. Because of the risk to reinfuse metastatic cells, the grafts were immunomagnetically purged. After preparation of the buffy coat fraction, mononuclear cells (mnc) and progenitor cells (CFU-GM) were enriched by density centrifugation and incubated successively with a cocktail of five tumour reacting monoclonal antibodies and magnetic microparticles. Target cells were removed by a set of samarium cobalt magnets. The purged grafts were stored in liquid nitrogen. After the complete procedure, an average of 16% nucleated cells of the initial harvest could be recovered. This corresponds with a mean number of 0,5 .times. 108 mnc and 2,4 .times. 104 CFU-GM per kg body weight being available for grafting. So far, 5 patients received their purged marrow graft and showed a sustained take.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007431123

Download citation: RISBibTeXText

PMID: 2164315

DOI: 10.1080/17843286.1990.11718073


Related references

Immunomagnetic purging of neuroblastoma cells from autologous bone marrow. Areman, E M , H J Deeg And R A Sacher (Ed ) Bone Marrow And Stem Cell Processing: A Manual Of Current Techniques Xxxi+487p F A Davis Co : Philadelphia, Pennsylvania, Usa Illus 267-273, 1992

Development of a large scale immunomagnetic separation system or purging neuroblastoma cells from autologous bone marrow. Experimental Hematology (Charlottesville) 20(6): 727, 1992

Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplantation 7(2): 145-151, 1991

Immunomagnetic purging of neoplastic b cells from bone marrow for autologous transplantation. Onkologie 14(SUPPL 2): 118, 1991

Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients. Progress in Clinical and Biological Research 377: 289-296, 1992

Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies. Haematologica 76 Suppl 1: 37-40, 1991

Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma. Progress in Clinical and Biological Research 377: 71-78, 1992

In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation. Journal of Clinical Oncology 14(10): 2791-2802, 1996

Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission. Annals of Hematology 81(10): 575-581, 2002

Immunomagnetic purging and autologous transplantation in stage d neuroblastoma. Bone Marrow Transplantation 2(SUPPL 2): 89-93, 1987

Purging of autologous bone marrow grafts in children with high-risk neuroblastoma by temporary iron removal. Pediatric Research 37(4 PART 2): 165A, 1994

Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation. Bone Marrow Transplantation 2(4): 413-419, 1987

Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging. Transplantation Proceedings 25(3): 2375-2376, 1993

Cost analysis of immunomagnetic marrow purging for neuroblastoma: in-house purging versus submission to purging centers. Journal of HematoTherapy 4(1): 41-44, 1995

Use of marker genes to investigate the mechanism of relapse and the effect of bone marrow purging in autologous transplantation for stage D neuroblastoma. Human Gene Therapy 4(6): 809-820, 1993